1-2 of 2
Laura Faglioni, MD
Close
Sort by
Journal Articles

Response to Erythropoietin in Different Karyotipic Subsets of Myelodysplastic Syndromes (MDS) and MDS with Sideroblasts: Multicentric Real-Life Experience from the Grom-L Cooperative Group

Roberto Latagliata, Pasquale Niscola, MD, Luana Fianchi, MD, Laura Faglioni, MD, Alessia Campagna, MD, Luca Maurillo, MD, PhD, Chiara Sarlo, MD, Annalina Piccioni, MD, Marianna Criscuolo, Ida Carmosino, Alessandro Andriani, MD, Svitlana Gumenyuk, Nicoletta Villivà, Daniela De Benedictis, MD, Roberta Battistini, MD, Susanna Fenu, Massimo Breccia, MD PhD, Stefano Mancini, MD, Maria Teresa Voso, MD, Maria Antonietta Aloe Spiriti, MD, Francesco Buccisano, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4262.
https://doi.org/10.1182/blood.V130.Suppl_1.4262.4262
Published: 2017
Journal Articles

Is Deferasirox Safe and Effective in Very Elderly Patients (> 75 Years) with Myelodysplastic Syndromes and Transfusional Iron Overload?

Roberto Latagliata, Pasquale Niscola, MD, Antonio Volpe, MD, Claudia Baratè, MD PhD, Alessia Campagna, MD, Antonella Poloni, PhD MD, Chiara Sarlo, MD, Laura Faglioni, MD, Daniela De Benedictis, MD, Ida Carmosino, Susanna Fenu, Maria Antonietta Aloe Spiriti, MD, Sara Galimberti, PhD MD, Massimo Breccia, MD PhD, Robin Foà, MD, Carlo Finelli, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4263.
https://doi.org/10.1182/blood.V130.Suppl_1.4263.4263
Published: 2017